Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.

BACKGROUND Renal artery stenosis (RAS) is a relatively uncommon but potentially reversible cause of renal failure. In a previous report, we demonstrated that the presence of RAS is independently associated with mortality in a group of patients undergoing coronary angiography. Our current study expands on this cohort, investigating the effect of the severity of RAS on all-cause mortality. METHODS A total of 3987 patients underwent abdominal aortography immediately following coronary angiography. For the purpose of survival analysis, significant RAS was defined as > or =75% narrowing in the luminal diameter. RESULTS Significant RAS was present in 4.8% of patients studied and was bilateral in 0.8%. Factors associated with the presence of RAS included female gender, older age, hypertension, congestive heart failure, elevated serum creatinine, and congestive heart failure. The four-year unadjusted survivals for patients with and without significant RAS were 57 and 89%, respectively (P < 0.001). Using the Cox proportional hazards model, the factors independently associated with decreased survival were the presence of RAS, increased age, the severity of coronary artery disease, the presence of comorbid disease, reduced ejection fraction, symptoms of congestive cardiac failure, and the mode of treatment of coronary artery disease. In the multivariate model, the presence of RAS conferred a hazard ratio of 2.01 (95% CI, 1.51 to 2.67, P < 0.001). We demonstrated an incremental effect on mortality according to the severity of RAS at baseline. Four-year adjusted survival for patients with 50%, 75%, and > or =95% stenosis was 70%, 68%, and 48%, respectively. In addition, bilateral disease was associated with four-year survival of 47% as compared with 59% for patients with unilateral disease (P < 0.001). The impact of RAS on survival remained robust regardless of the manner of treatment of coronary artery disease [that is, medical, percutaneous transluminal coronary angioplasty (PTCA), or coronary artery bypass graft (CABG)]. CONCLUSIONS In this patient population, the presence of RAS is a strong independent predictor of mortality. Increasing severity of RAS has an incremental effect on survival probability.

[1]  John B. Wong,et al.  Using observational data to estimate prognosis: an example using a coronary artery disease registry , 2001, Statistics in medicine.

[2]  W. Hsueh,et al.  Angiotensin II Enhances Integrin and α-Actinin Expression in Adult Rat Cardiac Fibroblasts , 2000 .

[3]  P. Kalra,et al.  Individual kidney function before and after renal angioplasty , 1998, The Lancet.

[4]  K. Baboolal,et al.  Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease , 1998 .

[5]  F. Taggi,et al.  Ischemic Nephropathy in an Elderly Nephrologic and Hypertensive Population , 1998, American Journal of Nephrology.

[6]  J. Webster,et al.  Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis , 1998, Journal of Human Hypertension.

[7]  Pierre-François Plouin,et al.  Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. , 1998, Hypertension.

[8]  D. Mark,et al.  Survival in renal vascular disease. , 1998, Journal of the American Society of Nephrology : JASN.

[9]  T. Scheerlinck,et al.  Screening for concomitant diseases in peripheral vascular patients. Results of a systematic approach. , 1997, International angiology : a journal of the International Union of Angiology.

[10]  N. Polissar,et al.  A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. , 1995, American journal of hypertension.

[11]  A. Bellucci,et al.  Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  F. Harrell,et al.  Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. , 1994, Circulation.

[13]  F P Cappuccio,et al.  Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. , 1994, The American journal of medicine.

[14]  R. J. Valentine,et al.  Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: Refined indications for preoperative aortography , 1993, Annals of vascular surgery.

[15]  L. Smith,et al.  Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. , 1992, Journal of the American Society of Nephrology : JASN.

[16]  G. Dusting,et al.  AUTORADIOGRAPHIC LOCALIZATION OF ANGIOTENSIN‐CONVERTING ENZYME AND ANGIOTENSIN II BINDING SITES IN EARLY ATHEROMA‐LIKE LESIONS IN RABBIT ARTERIES , 1991, Clinical and experimental pharmacology & physiology.

[17]  M. Daemen,et al.  Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. , 1991, Circulation research.

[18]  R. Wilkinson,et al.  Survival Associated with Renovascular Disease in Glasgow and Newcastle: A Collaborative Study , 1990, Scottish medical journal.

[19]  C. Johnston,et al.  Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. , 1990, The Journal of laboratory and clinical medicine.

[20]  J. Moorhead,et al.  Atherosclerotic renovascular disease causing renal impairment--a case for treatment. , 1989, Clinical nephrology.

[21]  S. Sheps,et al.  Clinical course of atherosclerotic renovascular disease. , 1968, The American journal of cardiology.